- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 221/22 - Systèmes cycliques pontés
Détention brevets de la classe C07D 221/22
Brevets de cette classe: 229
Historique des publications depuis 10 ans
|
17
|
11
|
9
|
16
|
14
|
5
|
10
|
8
|
15
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Rensselaer Polytechnic Institute | 830 |
8 |
| Boehringer Ingelheim International GmbH | 4648 |
7 |
| Alkermes Pharma Ireland Limited | 270 |
7 |
| Bristol-myers Squibb Company | 4850 |
6 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3186 |
6 |
| SpecGx LLC | 187 |
6 |
| Yunnan Haopy Pharmaceuticals Ltd | 8 |
6 |
| Merck Patent GmbH | 5773 |
5 |
| Takeda Pharmaceutical Company Limited | 2706 |
5 |
| Purdue Pharma L.P. | 502 |
5 |
| Yale University | 2422 |
5 |
| University of Florida Research Foundation, Inc. | 4052 |
4 |
| Universite de Rouen | 104 |
4 |
| Board of Regents, The University of Texas System | 5884 |
3 |
| Nippon Soda Co., Ltd. | 892 |
3 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 836 |
3 |
| Southwest Jiaotong University | 172 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2882 |
3 |
| C4 Theraprutics, Inc. | 59 |
3 |
| Merck Sharp & Dohme LLC | 3756 |
3 |
| Autres propriétaires | 134 |